VR Therapy for Dementia
(VR&R Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how Virtual Reality (VR) therapy at home might assist people with dementia and their caregivers. It aims to determine if VR can ease behavioral symptoms like mood swings and agitation while providing caregivers with opportunities to relax and reduce stress. Participants will try various VR experiences using immersive VR therapy in a head-mounted device (HMD) to identify the most effective options. The trial seeks individuals with dementia who live at home with a family caregiver and are 65 or older. As an unphased trial, this study offers a unique opportunity to explore innovative VR therapy and contribute to groundbreaking research.
Do I need to stop my current medications for the VR Therapy for Dementia trial?
The trial protocol does not specify whether you need to stop taking your current medications. It seems likely that you can continue your medications, but please confirm with the trial organizers.
What prior data suggests that this VR therapy is safe for individuals with dementia?
Research shows that virtual reality (VR) therapy is generally safe for people with dementia. Studies have found that VR can enhance emotional and social well-being without causing harm. For instance, a review found that VR had a positive or neutral effect on mood and social interactions in people with dementia, meaning most felt better or the same after VR sessions.
Another study highlighted that VR sessions are often passive, requiring little movement or interaction, which can be easier for older adults. Importantly, these studies reported no major negative side effects, suggesting that VR therapy is well-tolerated by people with dementia.
In conclusion, while more research is always beneficial, current evidence supports the safety of VR therapy for individuals with dementia.12345Why are researchers excited about this trial?
Researchers are excited about VR therapy for dementia because it's a novel, immersive approach that engages patients in a completely new way. Unlike traditional treatments that typically involve medications aiming to manage symptoms, VR therapy uses a head-mounted device to create an interactive environment, potentially improving cognitive function and mood. This method allows caregivers some respite while ensuring patients receive engaging, supervised therapy at home. The unique aspect of this trial is its focus on both solo and social use of VR, which could reveal how different interactions impact the patient's experience and outcomes.
What evidence suggests that VR therapy is effective for dementia?
Research shows that virtual reality (VR) therapy can enhance cognitive and physical abilities in people with Alzheimer's and dementia. Studies have found that VR experiences can boost mood and help maintain cognitive skills during treatment. In this trial, participants will be divided into two groups: one group will start VR therapy with only the caregiver present, while the other will begin with a research assistant present. VR therapy is safe and enjoyable, offering a satisfying experience for older adults with memory and cognitive challenges. Although improvements in quality of life are not as pronounced, the therapy positively affects overall well-being. Overall, VR therapy is a promising tool for managing dementia symptoms and enhancing the lives of both patients and caregivers.25678
Are You a Good Fit for This Trial?
This trial is for people with dementia aged 65 or older living at home with a family caregiver who can access the internet. Caregivers should be able to speak and understand English, provide consent, and assist their loved one. Excluded are those with certain legal guardianships, language barriers, pacemakers, blindness, open facial wounds (except sutured lacerations), seizure history, recent head trauma or stroke, unsafe cervical conditions for VR use, or alcohol-related dementia.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Initial Training
Participants take part in an initial at-home VR technology training session and complete a series of brief questionnaires
VR Therapy
Participants use VR&R therapy for a period of 4 weeks, with sessions lasting 30 minutes each
Follow-up
Participants provide feedback on the VR&R intervention in semi-structured interviews and answer additional questionnaires
What Are the Treatments Tested in This Trial?
Interventions
- Immersive VR Therapy in Head-Mounted Device (HMD)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University Health Network, Toronto
Lead Sponsor
Canadian Institutes of Health Research (CIHR)
Collaborator
Centre for Aging and Brain Health Innovation
Collaborator
Ontario AHSC AFP Innovation Fund
Collaborator